Dr David Bulmer
Dr Bulmer is a University Lecturer in the Department of Pharmacology of the University of Cambridge.
After a short spell as a post doctoral researcher (University of Sheffield) following completion of undergraduate (BSc (Pharmacology) University of Manchester) and postgraduate (PhD (Physiology) University College London) degrees, Dr Bulmer joined GlaxoSmithKline (GSK). At GSK, David led a translational biology group, in addition to early and late stage drug discovery programs. In 2009 he left GSK on an MRC Skills Gap Award to join Barts and the London School of Medicine and Dentistry, Queen Mary University of London (QMUL) as a lecturer in translational Neuroscience. In 2017 he was appointed to a lectureship at the Department of Pharmacology at the University of Cambridge.
Dr Bulmer's research looks at the mediators and mechanisms of abdominal pain in gastrointestinal disease. In particular, Dr Bulmer’s group has pioneered the use of human tissue to study pain processing from the gastrointestinal tract (visceral nociception) in diseases such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). His current work is focused on the role of ion channels as effectors of sensory nerve activation in IBS, and matrix metalloproteinases (MMPs) as novel mediators of visceral nociception in IBD. Further details of Dr Bulmer’s research interests can be found here: